In vitro activity of the trinem sanfetrinem (GV104326) against gram- positive organisms

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2142-2146

  Singh, Kavindra V ^a   Coque, Teresa M ^a   Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; GENTAMICIN; NAFCILLIN; SANFETRINEM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; INOCULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0029838479     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2142     Document Type: Article

References (37)

1. Arduino, R. C., and B. E. Murray. 1993. Enterococcus: antimicrobial resistance, p. 3-15. In G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practice of infectious diseases, vol. 2. Churchill Livingstone Inc., New York.
2. Bush, K. 1989. Characterization of β-lactamases. Antimicrob. Agents Chemother. 33:259-263.
3. Buu-Hoi, A., C. Branger, and J. F. Acar. 1985. Vancomycin-resistant streptococci or Leuconostoc spp. Antimicrob. Agents Chemother. 28:458-460.
4. Colman, G., and A. Efstratiou. 1987. Vancomycin-resistant leuconostocs, lactobacilli and now pediococci. J. Hosp. Infect. 10:1-3.
5. Coovadia, Y. M., Z. Solwa, and J. van den Ende. 1987. Meningitis caused by vancomycin-resistant Leuconostoc sp. J. Clin. Microbiol. 25:1784-1785.
6. Di Modugno, E., I. Erbetti, L. Ferrari, G. Galassi, S. M. Hammond, and L. Xerri. 1994. In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria. Antimicrob. Agents Chemother. 38:2362-2368.
7. Fontana, R., M. Aldegheri, M. Ligozzi, H. Lopez, A. Sucari, and G. Satta. 1994. Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 38:1980-1983.
8. Gutmann, L., M. D. Kitzis, and J. F. Acar. 1990. Evolution of enzymatic mechanisms of resistance among B-lactam antibiotics. J. Int. Med. Res. 18(Suppl. 4):37D-47D.
9. Hackbarth, C. J., and H. F. Chambers. 1989. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob. Agents Chemother. 33:991-994.
10. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wollf, and B. Walter. 1993. Nosocomial outbreak due to Enterococcus faecium resistant to vancomycin, penicillin and gentamicin. Clin. Infect. Dis. 16:750-755.
11. Handwerger, S., and A. Tomasz. 1986. Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance. J. Infect. Dis. 153:83-89.
12. Hartman, B. J., and A. Tomasz. 1984. Low-affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureus. J. Bacteriol. 158:513-516.
13. Hecht, D. W., and L. Lederer. 1995. In vitro activity of GV104326 compared with six other antibiotics against anaerobic bacteria, abstr. F137, p. 137. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Hideaki, H., H. Akagi, Y. Masaru, T. Otani, A. Hyodo, and K. Hiramatsu. 1995. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1120-1126.
15. Horowitz, H. W., S. Handwerger, K. G. van Horn, and G. P. Wormser. 1987. Leuconostoc, an emerging vancomycin-resistant pathogen. Lancet ii:1329-1330.
16. Malouin, F., and L. E. Bryan. 1986. Modification of penicillin-binding proteins as mechanisms of β-lactam resistance. Antimicrob. Agents Chemother. 30:1-5.
17. Maple, P. A. C., J. M. T. Hamilton-Miller, and W. Brumfitt. 1989. World wide antibiotic-resistance in methicillin-resistant Staphylococcus aureus. Lancet i:537-540.
18. Maza, L. D., K. L. Ruoff, and M. J. Ferraro. 1989. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. Antimicrob. Agents Chemother. 33:1383-1384.
19. Moellering, R. C., Jr. 1992. Emergence of enterococcus as a significant pathogen. Clin. Infect. Dis. 14:1173-1178.
20. Moellering, R. C., Jr., C. Wennersten, and A. N. Weinberg. 1971. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. J. Lab. Clin. Med. 77:821-828.
21. Montecalvo, M. A., H. Horowitz, C. Gedris, C. Carbonaro, F. C. Tenover, A. Issah, P. Cook, and G. P. Wormser. 1994. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob. Agents Chemother. 38:1363-1367.
22. Murray, B. E. 1990. The life and times of the enterococcus. Clin. Microbiol. Rev. 3:46-65.
23. Murray, B. E. 1991. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J. Infect. Dis. 163:1185-1194.
24. Murray, B. E. 1992. β-Lactamase-producing enterococci. Antimicrob. Agents Chemother. 36:2355-2359.
25. National Committee for Clinical Laboratory Standards. 1992. Methods for determining bactericidal activity of antimicrobial agents. NCCLS document M26-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
26. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard, NCCLS document M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
27. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
28. Nicas, T. L, C. T. Cole, D. A. Preston, A. A. Schabel, and R. Nagarajan. 1989. Activity of glycopeptides against vancomycin-resistant gram-positive bacteria. Antimicrob. Agents Chemother. 33:1477-1481.
29. Nordmann, P., M. Keller, F. Espinasse, and E. Ronco. 1994. Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates. J. Clin. Microbiol. 32:377-383.
30. Perboni, A., B. Tamburini, T. Rossi, D. Donati, and G. Gaviraghi. 1993. Tribactams: a novel class of β-lactams, p. 21-33. In P. H. Bentley and R. Ponsford (ed.), Recent advances in the chemistry of anti-infective agents, vol. 119. Royal Society of Chemistry (Great Britain), London.
31. Rubin, L. G., E. Vellozzi, J. Shapiro, and H. O. Isenberg. 1987. Infection with vancomycin-resistant "streptococci" due to Leuconostoc species. J. Infect. Dis. 157:216.
32. Sandra, A. N. T., E. M. Baily, and M. J. Rybak. 1993. Enterococcus, an emerging pathogen. Ann. Pharmacother. 27:1231-1242.
33. Shlaes, D. M., and B. Binczewki. 1990. Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 9:106-110.
34. Soriano, F., J. Zapardiel, and E. Nieto. 1995. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob. Agents Chemother. 39:208-214.
35. Tomasz, A., H. B. Drugeon, H. M. de Lencastre, D. Jabes, L. McDougall, and J. Bille. 1989. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob. Agents Chemother. 33:1869-1874.
36. Utsui, Y., and T. Yokota. 1985. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 28:397-403.
37. Zerros, M. J., C. A. Kaufmann, P. M. Therasse, A. G. Bergmann, T. S. Mikesell, and D. R. Schaberg. 1987. Nosocomial infection by gentamicin resistant Streptococcus faecalis: an epidemiologic study. Ann. Intern. Med. 106:687-691.